Table 4.
Univariate analysis and different multivariate analysis models in which logarithmically transformed DAPSA score was used as a dependent variable.
| B | SE | Beta | t | P | |
|---|---|---|---|---|---|
| Model 1 (Univariate analysis) | |||||
| Log age | 2.595 | 0.652 | 0.409 | 3.979 | 0.000 |
| Log BMI | 2.395 | 1.360 | 0.196 | 1.762 | 0.082 |
| Log PSA duration | 0.416 | 0.142 | 0.380 | 2.931 | 0.005 |
| Log uric acid | 0.264 | 0.487 | 0.080 | 0.543 | 0.590 |
| Log CRP | 0.549 | 0.105 | 0.604 | 5.253 | 0.000 |
| Log triglycerides | 0.596 | 0.228 | 0.359 | 2.613 | 0.012 |
| Log BLC | 0.103 | 0.311 | 0.044 | 0.331 | 0.742 |
| Log MIG | 0.334 | 0.180 | 0.239 | 1.856 | 0.069 |
| Log IL17 | 0.561 | 0.102 | 0.551 | 5.486 | 0.000 |
| Log adiponectin | 0.064 | 0.369 | 0.021 | 0.173 | 0.864 |
| Log Leptin | 0.283 | 0.269 | 0.126 | 1.052 | 0.296 |
| Log rezistin | −1.060 | 0.590 | −0.211 | −1.797 | 0.077 |
| Log GLS | −5.920 | 1.011 | −0.550 | −5.854 | 0.000 |
| Log LVIDd | 4.033 | 1.988 | 0.225 | 2.029 | 0.046 |
| Log LADiam | 3.251 | 1.227 | 0.291 | 2.649 | 0.010 |
| Log TAPSE | −5.436 | 0.824 | −0.614 | −6.600 | 0.000 |
| Log MV | −1.175 | 0.436 | −0.299 | −2.695 | 0.009 |
| Log EE | −0.189 | 0.811 | −0.027 | −0.233 | 0.816 |
| Model 2 (Independent variables: Log age, Log CRP, Log triglycerides, Log IL-17, Log GLS) | |||||
| Log CRP | 0.362 | .109 | 0.478 | 3.308 | 0.002 |
| Log triglycerides | 0.486 | .218 | 0.318 | 2.226 | 0.033 |
| Model 3 (Independent variables: Log GLS, Log IL-17, Log BLC) | |||||
| Log IL-17 | 0.398 | 0.112 | 0.397 | 3.542 | 0.001 |
| Log GLS | −4.365 | 1.305 | −0.375 | −3.346 | 0.001 |
| Model 4 (Independent variables: Log GLS, Log IL-17, Log BLC, Log BMI and Log age) | |||||
| Log IL-17 | 0.415 | 0.105 | 0.418 | 3.963 | < 0.001 |
| Log GLS | −3.210 | 1.264 | −0.277 | −2.539 | 0.014 |
| Age | 0.045 | 0.015 | 0.303 | 3.065 | 0.003 |
B unstandardized coefficient; SE standard error; Beta Standard coefficient, DAPSA Disease Activity in Psoriatic arthritis, PSA psoriatic arthritis, GLS global longitudinal strain, IL-17 interleukin 17, CRP C reactive protein, BMI body mass indeks, LVIDd left ventricular internal diameter at end-diastole, LADiam left atrium diameter, TAPSE tricuspid annular plane systolic excursion, MV mitral valve, E/E early diastolic mitral inflow velocity to early diastolic mitral annulus velocity, GLS global longitudinal strain, BLC B lymphocyte chemoattractant, MIG monokine induced by intereferon gamma.
Model 1—Univariate analysis (LogDAPSA set as dependent variable, independent variables were comprised of all cytokines, echo parameters and other parameters with statistical significant difference in prior analyses).
Model 2—Regional multivariate analysis where LogDAPSA was used as dependent variable, while independent variables were comprised of all parameters that showed statistical significant association in univariate analysis (Log Age, Log CRP, Log triglycerides, Log IL-17, Log GLS).
Model 3—Regional multivariate analysis where LogDAPSA was used as dependent variable, while independent variables were chosen at author’s discretion based on previous analyses (Log GLS, Log IL-17, Log BLC).
Model 4—Regional multivariate analysis where LogDAPSA was used as dependent variable, while independent variables were chosen at author’s discretion based on previous analyses (Log GLS, Log IL-17, Log BLC, BMI and age).